01 July 2026

Klaus Faber Institute in Neuroimmunology establishes new professorship

Gruppenbild© Thorsten Mohr/UdS
Bei der Vertragsunterzeichnung für eine Stiftungsprofessur für Neuroimmunologie waren anwesend (v.l.n.r.): Ulrike Freidinger, Geschäftsführerin der Medizinischen Fakultät, Matthias Hannig, Dekan der Fakultät, Universitätspräsident Ludger Santen sowie die Klaus-Faber-Vorstandsmitglieder Gerhard Pfefferle, Andreas Schmitt und Peter Schweitzer.

The non-profit Klaus Faber Foundation is funding the establishment of a W2 endowed professorship at the Klaus Faber Institute in Neuroimmunology, which is being developed as a part of the Faculty of Medicine on the Homburg campus. The institute aims to systematically decode neuroimmunological mechanisms and develop new approaches to diagnose and treat neuroimmunological diseases – in particular multiple sclerosis.

The following text has been machine translated from the German with no human editing.


For the non-profit Klaus Faber Foundation, multiple sclerosis is a key focus of its funding projects, which are primarily aimed at supporting science and research in medicine. The endowed professorship in neuroimmunology will receive funding of 1.3 million euros over five years. At Saarland University's Homburg Campus, the Klaus Faber Institute for Neuroimmunology, established in 2025, is integrated into the Faculty of Medicine's basic biomedical research. Further information can be found in the press release dated 15 April 2025.
 

Background on the Klaus Faber Foundation

The Klaus Faber Foundation is the sole shareholder of Klaus Faber AG, based in Saarbrücken, one of Europe's largest cable distributors and a leading systems provider in the cable and wiring industry. The Foundation primarily supports projects in basic medical research as well as initiatives in applied medicine. At Saarland University, the Klaus Faber Foundation has already funded the endowed chair in Drug Bioinformatics, which was established in 2018 in collaboration with the Helmholtz Institute for

Pharmaceutical Research Saarland (HIPS). Furthermore, in 2018, it established the Klaus Faber Centre for Corneal Diseases (KFZH) within the Eye Clinic at Saarland University Hospital . In the field of neuroimmunology, the Foundation is already active at universities in Göttingen, Freiburg and Munich.


Further information:https://klausfaberstiftung.de/

A press photo is available for download at the very bottom of the following webpage for royalty-free use in connection with this press release.

Gruppenbild© Thorsten Mohr/UdS
Bei der Vertragsunterzeichnung für eine Stiftungsprofessur für Neuroimmunologie waren anwesend (v.l.n.r.): Ulrike Freidinger, Geschäftsführerin der Medizinischen Fakultät, Matthias Hannig, Dekan der Fakultät, Universitätspräsident Ludger Santen sowie die Klaus-Faber-Vorstandsmitglieder Gerhard Pfefferle, Andreas Schmitt und Peter Schweitzer.